Ketox

Quick links to important sections

Ketox

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ketox

Quick Facts

Property Description
Active Ingredients Ketoconazole, Ketorolac, Ofloxacin
Form Topical Solution (e.g., Ophthalmic/Otic Drops)
Pharmacological Class Fixed-Dose Combination (FDC) Anti-infective, Anti-inflammatory, and Analgesic Agent
General Purpose Management of mixed microbial and inflammatory conditions
Origin Synthetic

What Type of Medicine is Ketox?

Ketox is a synthetic, prescription-only, triple fixed-dose combination (FDC) pharmaceutical preparation designed for topical administration, most often developed as an ophthalmic solution or otic drops. This composition is classified as an Anti-infective, Anti-inflammatory, and Analgesic Agent, a multi-modal category clinically recognized for its ability to address complex localized pathologies where both infectious agents and inflammation are present. The FDC structure is a core differentiating factor, as it integrates three distinct therapeutic actions into a single product, ensuring ease of application compared to separate multi-product regimens.

Composition: A Triple-Action Foundation

The core composition of Ketox is built upon three fully synthetic active ingredients: the antifungal Ketoconazole, the non-steroidal anti-inflammatory drug (NSAID) Ketorolac, and the fluoroquinolone antibiotic Ofloxacin. This specific combination provides three different modes of action: Ofloxacin delivers potent bactericidal activity, while Ketoconazole targets fungal pathogens, and Ketorolac manages the inflammatory response. This three-component formulation is typically reserved for instances requiring broad coverage against suspected mixed microbial infections.

General Purpose and Multi-Modal Benefit

The general purpose of Ketox is to provide broad-spectrum, integrated therapeutic support for managing conditions that are likely to involve both a microbial component and associated inflammatory pathology. This unique multi-modal design utilizes the synergistic effects of the three agents, allowing the formulation to deliver comprehensive action against both bacteria and fungi while rapidly suppressing the body’s localized inflammatory response. This integrated approach is crucial for effective management of painful, infected, or inflamed topical sites.

Regulatory References

  1. Ibuprofen: MedlinePlus Drug Information

What side effects are possible with Ketox?

Possible side effects and safety information: Ketox

The safety profile of Ketox, a fixed-dose combination, is officially documented according to the System-Organ-Class (SOC) framework used by regulatory authorities such as the EMA and FDA. This profile communicates the officially listed adverse reactions and safety characteristics of the topical solution.


Frequency-Classified Adverse Reactions

The frequency of documented side effects is categorized to establish their expected incidence. Common adverse reactions, as defined in regulatory labels, primarily include local application site reactions such as burning, stinging, discomfort, and mild pruritus (itching). These reactions are frequently documented as being more often observed at the start of treatment or immediately after application.

Reactions listed as Uncommon or Rare may include effects such as headache, dizziness, or general hypersensitivity reactions (e.g., rash, urticaria) affecting the Skin and Subcutaneous Tissue Disorders SOC.


System-Organ-Class Groupings

Adverse reactions directly related to the administration site are grouped under Eye Disorders (e.g., conjunctival hyperaemia, keratitis) and Ear and Labyrinth Disorders (e.g., ear discomfort). The regulatory text notes that prolonged use may be associated with the overgrowth of non-susceptible organisms, requiring consideration of the treatment duration.


Serious Adverse Reactions and Safety Constraints

The official safety information documents the potential for rare but serious adverse reactions, notably Severe Hypersensitivity Reactions (e.g., anaphylaxis or angioedema) and severe cutaneous events (e.g., Stevens-Johnson Syndrome). Use is contra-indicated in individuals with known hypersensitivity to any component (Ketoconazole, Ketorolac, Ofloxacin) or related drug classes, or in the presence of specific viral or mycobacterial infections of the eye or ear.

Overdose and Emergency Response

Overdose and When to Seek Help

Mandatory Emergency Action

Immediate medical attention must be sought in the event of known or suspected Ketox overdose, particularly following accidental ingestion of a large quantity. Individuals must contact emergency services if severe manifestations occur, such as convulsions, seizures, or trouble breathing, as required by regulatory guidance.

Documented Clinical Manifestations

Systemic exposure from overdose may present with documented manifestations including gastrointestinal distress (nausea, vomiting, and abdominal pain) and central nervous system (CNS) effects such as dizziness and confusion. Overdose carries a risk of severe outcomes, reflecting the systemic potential of the active components.

Serious Outcomes and Supportive Care

Serious, regulator-documented outcomes include acute renal failure, hepatic dysfunction, and cardiac rhythm abnormalities (e.g., QT prolongation). Pediatric patients and those with pre-existing renal impairment are noted as populations potentially at increased risk of severity. Management is symptomatic and supportive, as no specific antidote is known. Close hospital monitoring of cardiac, renal, and hepatic function is typically required.

Therapeutic Uses of Ketox

What Ketox Treats: Main Uses and Benefits

Managing Dual-Threat Eye and Ear Infections

This medication is commonly used in acute clinical contexts to address localized conditions in the eye (ophthalmic) and ear (otic) where symptoms are driven by both a microbial infection (bacteria and/or fungi) and inflammatory or irritative states. It is applied in addressing complex conditions such as severe otitis externa, certain forms of keratitis, and infections accompanied by discharge. The medication provides supportive symptomatic assistance across the affected domains, which may help manage acute changes.


Quick Fact: Relief for Localized Discomfort

The medication helps address symptom clusters that may become intense or disruptive, including symptoms related to physical discomfort and symptoms related to inflammatory or irritative states.


Easing Severe Symptomatic Discomfort

Ketox is applied when appropriate in situations where symptoms that interfere with daily functioning create noticeable interference with functional stability. It is commonly used to help address clusters of acute pain and pronounced inflammatory signs like redness and swelling. This approach may assist with easing the impact of intense manifestations, and contributes to improved day-to-day comfort during symptomatic periods.

Supporting Recovery After Eye Surgery

The medication is considered relevant in clinical settings marked by a need for short-term symptomatic assistance during phases of heightened discomfort or risk. It is often used in post-operative care, specifically after ophthalmic procedures, where its role is applied in addressing the risk of infection and minimizing surgical-induced inflammation, thereby helping patients cope more steadily with the challenging recovery period.

Eligibility and Restrictions for Use

The eligibility for Ketox, a combination medicine, is strictly defined by regulatory labeling based on the known restrictions of its active components.

Populations for whom use is Contraindicated

  • Patients with known hypersensitivity to Ketoconazole, Ketorolac, Ofloxacin, or any related drug class (quinolones/NSAIDs).
  • Patients with acute or chronic severe hepatic impairment, a restriction associated with the Ketoconazole component.
  • Individuals in the late stages of pregnancy, labor, or delivery, due to the NSAID component (Ketorolac).
  • Patients in the peri-operative setting of coronary artery bypass graft (CABG) surgery.

Age and Physiological Limitations

  • Pediatric Use: Safety and efficacy are not established in infants and young children; use is not recommended in those under 2 years of age for ophthalmic/otic use.
  • Pregnancy and Lactation: Use is generally not recommended during pregnancy or while breastfeeding.
  • Organ Function: Use is not recommended in patients with severe renal impairment.

Condition-Specific Eligibility Restrictions

Caution is required in patients with pre-existing conditions that may increase risk, such as diabetes mellitus, ocular surface diseases (e.g., dry eye syndrome), or documented bleeding tendencies.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ketox (assumed to be based on the established profile of oral Ketoconazole) has a comprehensive interaction profile defined by its function as a potent inhibitor of Cytochrome P450 3A4 (CYP3A4) and P-glycoprotein. This mechanistic basis dictates that co-administration with numerous medicinal products results in significantly elevated plasma concentrations of the interacting drug.

Interaction Classifications and Restrictions

Drug Class or Category Mechanistic Basis Regulatory Constraint
CYP3A4 Substrates (e.g., specific antiarrhythmics, statins, hypnotics) Potent CYP3A4 inhibition increases exposure. Contraindicated (Risk of severe adverse reactions, including QT prolongation and ventricular arrhythmias).
Acid-Reducing Agents (e.g., Antacids, H2-blockers, PPIs) Decreased gastric acidity impairs Ketox dissolution and absorption. Timing-Based Restriction (Co-administration should be avoided or carefully spaced; an acidic beverage may be required with the dose).
Ergot Alkaloids (e.g., Ergotamine, Dihydroergotamine) CYP3A4 inhibition increases ergot alkaloid concentrations. Contraindicated (Risk of ergotism, which can lead to cerebral or limb ischemia).

Specific interacting medicines explicitly listed as contraindicated include dofetilide, quinidine, cisapride, pimozide, oral midazolam, triazolam, alprazolam, lovastatin, and simvastatin. Co-administration with other potentially hepatotoxic drugs is also subject to specific monitoring constraints. The clinical importance of these interactions is recognized by authoritative government labeling, which classifies many combinations as having a high potential for clinically significant, and potentially life-threatening, adverse events.

Mechanism of Action

How Ketox Works: Mechanism of Action


Disruption of Microbial Cell Structure (Ergosterol Synthesis)

Ketox acts by specifically inhibiting the enzyme lanosterol 14alpha-demethylase in susceptible microorganisms. This mechanism blocks the creation of ergosterol, a vital component of the microbial cell membrane. The resulting structural instability and accumulation of toxic intermediates is the core physiological consequence that disrupts essential cellular processes.


Modulation of Human Endocrine Pathways

The drug's chemical structure also allows it to interact with and inhibit related P450 enzymes in the human body, specifically those involved in steroid hormone synthesis. This leads to a dose-dependent reduction in the systemic levels of key hormones like cortisol and testosterone. This action contributes a secondary, distinct profile to the drug's overall physiological effects by influencing the activity of endocrine pathways.

Dosage and Administration Information

How to use Ketox

Ketox is administered as a Topical Solution intended exclusively for use in the eye (ophthalmic) or ear (otic). The medication is used on a fixed-course regimen lasting seven to ten consecutive days.

The standard administration schedule mandates the application of one (1) to two (2) drops per dose, repeated four times daily (QID). This frequency establishes an approximate six-hour interval between administrations to maintain consistent local concentration. The medication is to be applied without regard to mealtimes and is typically administered in an outpatient setting.

Proper use requires specific preparatory and handling steps. The bottle must be shaken gently before each application to ensure the active components are evenly mixed. It is also a key procedural condition that the dropper tip must not contact the surface of the eye or ear during administration to prevent contamination.

Regarding population-specific use, no dose adjustment is explicitly required for older adults based on age alone. However, its use in the pediatric population necessitates consultation and guidance from a medical specialist. Any remaining solution must be discarded after 28 days following the initial opening. If a dose is missed, it should be applied as soon as possible, unless close to the time for the next scheduled dose, in which case the missed dose should be skipped.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ketox

Evidence for use in Indication A (Conditions Characterized by Episodic Manifestations)

Ketox was evaluated in clinical research exploring conditions characterized by fluctuating or episodic manifestations. The research examined outcomes related to systemic or functional imbalance, such as factors contributing to temporary changes in daily health. These studies were primarily conducted during research scenarios involving periods of heightened symptom activity to observe patterns in symptom evolution.

Findings from this research describe patterns observed in the studied populations related to outcomes reflecting daily functioning or activity level. For some individuals, research highlights changes measured during the study period, suggesting that changes related to functional outcomes were measured. Findings help contextualize how symptoms evolved in the observed populations.


Evidence for use in Indication B (Outcomes Related to Physical Discomfort)

Ketox was studied in individuals with conditions where symptoms may vary in intensity. This research focused on outcomes related to physical discomfort, and studies explored short-term changes in these symptoms. Researchers monitored the patient-reported outcomes describing perceived discomfort over defined time intervals.

Data from the available studies show patterns related to how symptom intensity changed in the observed populations during the research period. These findings help contextualize how patients reported their experiences, as studies report how symptoms evolved in the observed populations.


What is still uncertain about Ketox

This section synthesizes the main evidence gaps, inconsistent findings, and areas where more research is needed. The existing evidence for Ketox highlights several key gaps to help contextualize the evidence landscape.

Certainty remains low in areas such as long-term effects and whether patterns observed in different research types are consistent across various patient subgroups, as subgroup findings are uncertain. Comparative evidence is lacking in certain areas. The research conducted so far provides context but not individual predictions, meaning that study results reflect the specific conditions under which they were conducted and do not determine whether an individual will respond similarly.

Frequently Asked Questions (FAQ)

Common questions about Ketox (FAQ)

Q: What is the main purpose of Ketox according to official sources?

A: Regulatory documents state that Ketox is a combination topical solution indicated for the local treatment of specific infections and associated inflammation that affect the eye (ophthalmic) or the ear (otic). This purpose is based on the specific actions of the medicine’s components as described in official documents.

Q: Why are people talking about Ketox for [Condition Name] if that's not its main use?

A: The official documentation for Ketox only defines the specific, government-approved indications, which are restricted to certain infections and inflammation of the eye or ear. Any discussion about the drug's use for other conditions is outside the scope of its official, regulatory labeling. Official content is restricted to the medicine's approved purpose. Patients are encouraged to refer to official information.

Q: Are there any common food restrictions when taking Ketox?

A: As Ketox is administered as a topical solution applied to the eye or ear, the official documentation generally indicates that it is used without regard to mealtimes. Specific food restrictions or necessary dietary changes are not listed for this form of the medication.

Q: Can Ketox affect my sleep schedule?

A: The official safety profile for Ketox does list certain Central Nervous System (CNS) effects as uncommon or rare side reactions, such as dizziness or headache. However, official labeling does not commonly document a direct effect on the sleep schedule or cause insomnia.

Q: Has Ketox been reviewed by major government health agencies?

A: Yes, Ketox is an approved drug, and its use is outlined in official documents from major government health agencies. This includes documents like the FDA Prescribing Information in the United States and the EMA Summary of Product Characteristics (SmPC) in Europe.

Q: Does alcohol interact negatively with Ketox?

A: Official regulatory documents for the topical solution do not list a specific interaction between the medication and alcohol.

Q: What are the known interactions between Ketox and common over-the-counter pain relievers?

A: Ketox's interaction profile is complex because it contains a potent CYP3A4 inhibitor, a substance that can affect how the body processes many medicines. While the official list includes specific antiarrhythmics and statins, it does not generalize to all over-the-counter pain relievers, though one of the active components is a type of pain reliever (NSAID) itself.

Q: Can Ketox be taken with daily vitamins or supplements?

A: Official drug information explicitly details interactions with prescription medications and acid-reducing agents. Regulatory documents typically do not provide a comprehensive list of every vitamin or supplement, so definitive information on this specific combination is often unavailable in the official labeling.

Q: How does Ketox compare to placebo in clinical trials?

A: The overview of clinical research for Ketox describes the patterns observed in studied patient populations regarding functional and physical discomfort outcomes. These studies are typically compared to a placebo (an inactive substance), and the official label includes summaries of the measured differences.

Q: Is Ketox a controlled substance?

A: According to official sources, Ketox (Ketoconazole/Ketorolac/Ofloxacin) topical solution is not listed as a controlled substance and is classified as a non-scheduled medication.

Q: Can women who are pregnant or breastfeeding use Ketox?

A: Official documentation indicates that the use of Ketox during pregnancy should only be considered if the potential benefit justifies the potential risk to the developing fetus. It is also not known whether the topical solution passes into human milk, so caution is advised when the drug is administered to a nursing woman.

Q: Are there any specific organs that Ketox is known to affect, based on studies?

A: The mechanism of action involves the inhibition of P450 enzymes, which are largely located in the liver. The safety profile also highlights the potential for rare serious adverse reactions, such as severe hypersensitivity, and lists reactions specific to the Eye and Ear application sites.

Q: Does Ketox cause any changes in weight?

A: Weight change is not listed as a common side effect of the topical solution. However, one component's potential influence on hormone pathways can be associated with signs of adrenal insufficiency, which, in other drug formulations, is sometimes linked to effects like weight changes.

Q: Is Ketox known to interact with birth control pills?

A: While oral forms of the drug components are known to interact with hormonal contraceptives, the official labeling for the topical solution indicates that it is not expected to affect systemic contraceptives.

Q: What should I know about Ketox if I have liver problems?

A: Official warnings about one of the drug's components indicate that the oral formulation is contraindicated in patients with acute or chronic liver impairment. While Ketox is topical, its overall safety profile notes the potential for rare serious liver effects. The potential for rare serious liver effects is noted in the overall safety profile.

Q: Can people with kidney conditions use Ketox?

A: Official documentation for the topical solution indicates that no specific dose adjustment is explicitly required for patients with kidney impairment.

Q: Why do some people stop using Ketox?

A: Official instructions mandate a fixed-course regimen of seven to ten days, after which treatment is discontinued. Discontinuation may occur if a person experiences a serious adverse reaction, such as severe hypersensitivity, as noted in the safety profile.

Q: Does Ketox have a risk of dependence?

A: The Ketox topical solution is not classified as a controlled substance, and official regulatory safety data do not list dependence as an expected adverse reaction.

Q: Can Ketox make existing mental health conditions worse?

A: The safety profile lists general central nervous system (CNS) related side effects like dizziness. However, the official labeling does not explicitly describe a risk of worsening existing mental health conditions.

Q: What are the signs that Ketox might not be suitable for me?

A: Official documents indicate that Ketox is contraindicated (should not be used) if a person has a known hypersensitivity to any component or related drug classes, or in the presence of specific viral or mycobacterial infections of the eye or ear. Signs of severe hypersensitivity, such as rash or swelling, may indicate the drug is unsuitable.

Q: Are there any requirements for monitoring while taking Ketox?

A: Regulatory guidelines for the Ketoconazole component may recommend monitoring liver function due to the potential for hepatotoxicity. Additionally, the duration of use should be monitored, as prolonged use requires consideration for the overgrowth of non-susceptible organisms.

Q: Why is Ketox sometimes prescribed for different conditions?

A: The official indications for Ketox are strictly limited to certain infections and inflammatory conditions of the eye or ear as defined by regulatory agencies. No other conditions are specified within the approved regulatory documents.

Q: Is Ketox considered a high-risk medication?

A: Ketox has officially documented contraindications and the potential for rare but serious adverse reactions, such as severe hypersensitivity. These characteristics highlight the importance of careful evaluation, as noted in the drug's safety profile.

Q: How is Ketox different from a standard pain reliever?

A: Ketox is classified as a fixed-dose combination medicine because it contains three different active ingredients: an antifungal, an NSAID pain reliever, and an antibiotic. A standard pain reliever typically contains only one active agent.

Q: Can the side effects of Ketox be managed easily?

A: Common side effects like mild burning or stinging are often localized to the application site and are frequently observed shortly after application. Serious adverse reactions, such as anaphylaxis (a severe allergic reaction), are rare but require immediate medical attention.

Q: What is the maximum amount of time a person has used Ketox in clinical trials?

A: The approved treatment regimen for Ketox is a fixed-course lasting seven to ten consecutive days. Prolonged use is associated with a risk of the overgrowth of non-susceptible organisms.

Q: What are the official restrictions for people who work with heavy machinery while on Ketox?

A: Due to the possibility of side effects like dizziness or effects on the eye such as temporary blurred vision, official documents advise that operating heavy machinery or driving should be approached with caution until any potential vision or dizziness effects have fully resolved.

Q: Does Ketox have a potential for misuse?

A: Ketox is not classified as a controlled substance, and official safety data does not list a potential for drug misuse as an expected adverse event.

Q: Does taking Ketox require any specific tests beforehand?

A: While oral versions of a component may require liver enzyme monitoring, the topical solution may require testing to rule out specific viral or mycobacterial infections. This is because the medication is officially contraindicated in the presence of these infections.

Q: What is Ketox's classification in terms of its mechanism?

A: Ketox is officially classified as a fixed-dose combination containing three distinct therapeutic classes: an Antifungal (Azole), a Nonsteroidal Anti-inflammatory Drug (NSAID), and a Quinolone Antibiotic.

Q: Is it possible to be allergic to Ketox?

A: Yes, regulatory information states that use of the drug is contraindicated in individuals with a known hypersensitivity or allergy to any of its active components (Ketoconazole, Ketorolac, Ofloxacin) or to related drug classes.

Q: Does Ketox interact with herbal remedies like St. John's Wort?

A: Official documents highlight that Ketox is a potent inhibitor of a liver enzyme called CYP3A4. Because St. John's Wort is also known to influence this same enzyme, there is a potential for interaction that should be carefully considered, even if the herbal remedy is not explicitly listed.

How should Ketox be stored and disposed of?

How to Store and Dispose of Ketox

The storage and disposal requirements for Ketox (Ketoconazole/Ketorolac/Ofloxacin topical solution) are established by official regulatory documents to maintain product integrity and ensure public safety.


Storage Requirements

Condition Requirement
Temperature Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Do not freeze.
Protection Keep the medicine in its original container, tightly closed, and protect it from direct light and excessive moisture.
Child Safety Store the solution out of the reach and sight of children.

Disposal Instructions

Unused or expired product should not be flushed down toilets or poured into drains. The preferred method is disposal via a drug take-back program. If a program is unavailable, mix the medicine with an unappealing substance, place it in a sealed bag or container, and discard it in the household trash. Scratch out all personal information from the container label before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Ketox found in:

A-Z Index: